Big Pharma Probe


Surprise surprise. The US Department of Justice is now investigating Big Pharma for corruption.

The Financial Times reports that GlaxoSmithKline, Pfizer, Bristol-Myers Squibb, Eli Lilly and Merck are all being investigated. The US Government is looking at the payments they made for hospitality, consultants, licensing agreements and charitable donations in markets around the world. It's also looking at the recruitment of physicians for clinical trials and sticking the same physicians on to regulatory boards that approve or deny drugs.

In other words, the DOJ is examining allegations that the world's biggest pharmaceutical companies had engaged in systematic bribery around the world, in breach of US and other laws. More to the point, these corrupt payments might have "influenced" the "reliability or integrity" of data in clinical trials performed abroad, putting people's lives at risk.

Perhaps the DOJ can start with the latest findings of the World Health Organisation which, as reported here, has released the names of academics and advisors who influenced the WHO's decision to declare a phase six pandemic last year, and who also happened to receive money from vaccine companies. Declaring the pandemic created a financial bonanza for Big Pharma.

This is an important probe. It's not before time.


Related Articles:


From Dusk 'til Dawn
An Insider's View of the Growth of the Animal Liberation Movement

© Keith Mann